Nidovirus-Associated Proliferative Pneumonia in the Green Tree Python (Morelia viridis) by Dervas, Eva
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Nidovirus-Associated Proliferative Pneumonia in the Green Tree Python
(Morelia viridis)
Dervas, Eva
Abstract: Since 2014 we observed a noticeable increase in sudden deaths of green tree pythons (Morelia
viridis). A total of 12 affected green tree pythons from 7 different breeders were submitted for a diagnostic
post mortem examination. The gross examination revealed accumulation of mucus within airways and
lung, associated with enlargement of the entire lung. Histology showed marked hyperplasia of the airway
epithelium and faveolar type II pneumocytes. Using next-generation sequencing (NGS) on lung samples of
diseased snakes we identified a viral RNA genome that was approximately 85% identical with nidoviruses
previously identified in ball pythons and an Indian python. We then confirmed the presence of the
novel nidovirus in all diseased snakes by RT-PCR. To attempt virus isolation, we established primary
cell cultures of Morelia viridis liver and brain, these were inoculated with lung homogenates of diseased
snakes. Ultrastructural examination of concentrated cell culture supernatants revealed nidovirus particles,
and subsequent NGS analysis yielded the full genome of the novel Morelia viridis nidovirus (MVNV).
We then generated an antibody against MVNV nucleoprotein and MVNV specific oligoprobes and used
immunohistology and RNA in situ hybridisation to identify the viral target cells in the lungs. Nidoviruses
are a likely cause of severe pneumonia in pythons and cause sudden outbreaks in breeding collections.
Keywords: Nidovirus, pneumonia, Morelia viridis
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-144231
Published Version
Originally published at:
Dervas, Eva. Nidovirus-Associated Proliferative Pneumonia in the Green Tree Python (Morelia viridis).
2017, University of Zurich, Vetsuisse Faculty.
0 
 
Institut für Veterinärpathologie  
der Vetsuisse-Fakultät Universität Zürich 
 
 
 
Direktorin: Prof. Dr. med. vet. Anja Kipar 
 
 
 
Arbeit unter wissenschaftlicher Betreuung von 
Prof. Dr. med. vet. Anja Kipar 
 
 
Nidovirus-Associated Proliferative Pneumonia in the Green Tree Python 
 (Morelia viridis) 
 
 
 
 
 
Inaugural-Dissertation 
 
 
zur Erlangung der Doktorwürde der  
Vetsuisse-Fakultät Universität Zürich 
 
 
vorgelegt von 
 
 
 
Eva Dervas 
 
 
Tierärztin 
von Athen, Griechenland 
 
 
 
genehmigt auf Antrag von 
 
 
Prof. Dr. med. vet. Anja Kipar, Referentin 
 
 
2017 
 
 
 
 
 
   
1 
 
Institut für Veterinärpathologie  
der Vetsuisse-Fakultät Universität Zürich 
 
 
 
Direktorin: Prof. Dr. med. vet. Anja Kipar 
 
 
 
Arbeit unter wissenschaftlicher Betreuung von 
Prof. Dr. med. vet. Anja Kipar 
 
 
Nidovirus-Associated Proliferative Pneumonia in the Green Tree Python 
 (Morelia viridis) 
 
 
 
 
 
Inaugural-Dissertation 
 
 
zur Erlangung der Doktorwürde der  
Vetsuisse-Fakultät Universität Zürich 
 
 
vorgelegt von 
 
 
 
Eva Dervas 
 
 
Tierärztin 
von Athen, Griechenland 
 
 
 
genehmigt auf Antrag von 
 
 
Prof. Dr. med. vet. Anja Kipar, Referentin 
 
 
2017 
 
 
 
 
 
1 
 
 
INHALTSVERZEICHNIS 
 
1. Zusammenfassung 2 
2. Abstract 3 
3. Artikel 4-55 
4. Danksagung 56 
5. Lebenslauf 57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
Vetsuisse-Fakultät Universität Zürich 2017 
 
Eva Dervas 
 
Institut für Veterinärpathologie 
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Nidovirus- assoziierte proliferative Pneumonie im grünen Baumpython (Morelia viridis) 
 
Seit 2014 werden vermehrt plötzlich verstorbene Baumpythons zur diagnostischen postmortalen 
Untersuchung eingeschickt; insgesamt wurden 12 erkrankte Baumpythons von sieben verschiedenen 
Züchtern untersucht. In der makroskopischen Untersuchung waren vor allem eine ausgeprägte 
Schleimansammlung in den Atemwegen sowie  eine Verdickung der gesamten Lunge auffällig. 
Histologisch konnte eine Hyperplasie des respiratorischen Epithels und der Typ II Pneumozyten im 
Faveolarraum festgestellt werden. Mittels Next-generation sequencing (NGS) am Lungengewebe 
erkrankter Tiere konnte ein virales RNA-Genom identifiziert werden, dass 85 % identisch war mit 
beschriebenen Nidoviren bei Königspythen und einer Indischen Python. Mittels RT-PCR wurde 
anschliessend das neue Nidovirus in allen erkrankten Baumpython nachgewiesen. Es wurden 
Primärkulturen von Morelia viridis Leber- und Gehirnzellen etabliert, die zur Virusisolation aus 
Lungenhomogenaten erkrankter Tiere dienten. In den Überständen der infizierten Zelkulturen konnten 
elektronenmikroskopisch Nidoviruspartikel nachgewiesen werden; mittels abermaligem NGS konnte 
das vollständige Genom des Morelia viridis Nidovirus (MVNV) sequenziert werden. Mittels eines 
spezifischen Antikörpers gegen das MVNV Nukleoprotein sowie spezifischen Oligo-Riboproben und 
Immunhistologie bzw. in situ-Hybridisierung konnten die Zielzellen des Virus identifiziert werden. 
Nidovirus-Infektionen können zum plötzlichen Tod von Pythons führen und sind somit von 
zunehmender Bedeutung für Schlangenbestände.  
 
Stichwörter: Nidovirus, Pneumonie, Morelia viridis  
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Vetsuisse Faculty University of Zurich 2017 
 
Eva Dervas 
 
Institute of Veterinary Pathology 
ivpz@vetpath.uzh.ch 
 
Nidovirus-Associated Proliferative Pneumonia in the Green Tree Python (Morelia viridis) 
 
Since 2014 we observed a noticeable increase in sudden deaths of green tree pythons (Morelia viridis). 
A total of 12 affected green tree pythons from 7 different breeders were submitted for a diagnostic post 
mortem examination. The gross examination revealed accumulation of mucus within airways and lung, 
associated with enlargement of the entire lung. Histology showed marked hyperplasia of the airway 
epithelium and faveolar type II pneumocytes. Using next-generation sequencing (NGS) on lung 
samples of diseased snakes we identified a viral RNA genome that was approximately 85% identical 
with nidoviruses previously identified in ball pythons and an Indian python. We then confirmed the 
presence of the novel nidovirus in all diseased snakes by RT-PCR. To attempt virus isolation, we 
established primary cell cultures of Morelia viridis liver and brain, these were inoculated with lung 
homogenates of diseased snakes. Ultrastructural examination of concentrated cell culture supernatants 
revealed nidovirus particles, and subsequent NGS analysis yielded the full genome of the novel 
Morelia viridis nidovirus (MVNV). We then generated an antibody against MVNV nucleoprotein and 
MVNV specific oligoprobes and used immunohistology and RNA in situ hybridisation to identify the 
viral target cells in the lungs. Nidoviruses are a likely cause of severe pneumonia in pythons and 
cause sudden outbreaks in breeding collections. 
Keywords: Nidovirus, pneumonia, Morelia viridis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
4 
 
Nidovirus-Associated Proliferative Pneumonia in the Green Tree Python (Morelia 
viridis) 
 
 
Eva Dervas
1
, Jussi Hepojoki
1,2
, Andrea Laimbacher
3
, Fernando Romero-Palomo
1
, Christine Jelinek
1
, 
Saskia Keller
1
, Teemu Smura
2
, Satu Hepojoki
1
, Anja Kipar
1*
, Udo Hetzel
1
 
 
1
Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland 
2
University of Helsinki, Medicum, Department of Virology, Helsinki, Finland 
3
Institute of Virology, Vetsuisse Faculty, University of Zurich, Switzerland 
 
Running title: Morelia viridis nidovirus 
 
 
 
 
 
 
 
 
 
 
 
*Corresponding author’s address: 
Institute of Veterinary Pathology 
Vetsuisse Faculty 
University of Zurich 
Winterthurerstrasse 268 
CH - 8057 Zurich 
Switzerland 
 Phone: +41 44 6358552 
 E-mail: anja.kipar@uzh.ch 
 
5 
 
Abstract 
In 2014 we observed a noticeable increase in sudden deaths of green tree pythons (Morelia 
 
viridis). Pathological examination revealed accumulation of mucoid material within    airways 
 
and lung, associated with enlargement of the entire lung. We performed full necropsy and 
 
histological  examination  on  12  affected  green  tree  pythons  from  7  different  breeders to 
 
characterise the pathogenesis of this “mucinous” pneumonia. By histology we could show a 
 
marked  hyperplasia  of the  airway epithelium and  of faveolar  type II pneumocytes.     Since 
 
routine microbiological tests failed to identify a causative agent, we studied lung samples of a 
 
few diseased snakes by next-generation sequencing (NGS). From the NGS data we could 
 
assemble a piece of RNA genome <85% identical to nidoviruses previously identified in   ball 
 
pythons and Indian pythons. We then employed RT-PCR to demonstrate the presence of the 
 
novel nidovirus in all diseased snakes. To attempt virus isolation, we established primary  cell 
 
cultures of Morelia viridis liver and brain, which we inoculated with lung homogenates of 
 
infected  individuals.  Ultrastructural  examination  of  concentrated  cell  culture supernatants 
 
showed the presence of nidovirus particles, and subsequent NGS analysis yielded the full 
 
genome  of  the  novel  virus,  Morelia  viridis  nidovirus  (MVNV).  We  then  generated    an 
 
antibody against MVNV nucleoprotein, which we used alongside RNA in situ hybridisation 
 
to demonstrate viral antigen and RNA in the affected lungs. This suggests that in natural 
 
infection MVNV damages the respiratory tract epithelium which then results in epithelial 
 
hyperplasia, most likely as an exaggerated regenerative attempt in association with   increased 
 
epithelial turnover. 
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Importance 
 
 
Fairly recently novel nidoviruses associated with severe respiratory disease were identified  in 
 
ball pythons and Indian pythons. Herein we report isolation and identification of a further 
 
nidovirus from green tree pythons (Morelia viridis) with fatal pneumonia. We thoroughly 
 
characterize the pathological changes in the infected individuals, and show that nidovirus 
 
infection  is  associated  with  marked  epithelial  proliferation  in  the  respiratory  tract.    We 
 
speculate that this and the associated excess mucus production can lead to the animals’  death, 
 
by inhibitingthe normal gas exchange in the lung. The virus was predominantly detected in 
 
the respiratory tract, which renders transmission via the respiratory route likely.    Nidoviruses 
 
cause sudden outbreaks with high mortality in breeding collections, most affected snakes   die 
 
without prior clinical signs. These findings, together with those of other groups, indicate   that 
 
nidoviruses are a likely cause of severe pneumonia in pythons. 
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Introduction 
 
The green tree python or Southern green python, Morelia viridis (Schlegel, 1872), is an 
 
oviparous  boid   constrictor   snake  with   natural   habitats   in   several   Indonesian  islands, 
 
Florida, Papua New Guinea and North Australia (1). Over the recent years large numbers of 
 
M.  viridis  have  been  exported  from Indonesia  to Europe  and America  (2),  and  they have 
 
become  increasingly  popular  in  both private  and zoological collections (3,  4).  So  far,  the 
 
knowledge on infectious diseases of M. viridis is sparse (5). 
 
Recently, fatal pneumonias have been reported in two other python species, ball pythons 
 
(Python regius) (6) and Indian pythons (Python molurus) (7); infection with novel nidoviruses 
 
was  found  as  the  common  denominator  (8,  9).  The  described  viruses  are approximately 
 
equidistant  from  the  two  current  genera,  Torovirus  and  Bafinivirus,  of  the    Torovirinae 
 
subfamily in the family Coronaviridae, order Nidovirales (8–15), in which they will likely 
 
form a novel genus (9). 
 
The  order  Nidovirales  comprises  four  families  of  complex  positive-sense single-stranded 
 
RNA (ssRNA+) viruses, Arteriviridae, Mesoniviridae, Roniviridae and Coronaviridae, which 
 
are also distinguished by their genome size: roniviruses (~26 kb) and coronaviruses (26-33 
 
kb) are known as “large nidoviruses” (16–18), arteriviruses as “small nidoviruses” (13–16 
 
kb), and mesoniviruses with an intermediate genome size between the two (16, 17, 19, 20). 
 
While roniviruses and mesoniviruses are known to infect crustaceans and insects (19, 21), 
 
arteriviruses have been associated with an acute respiratory syndrome and abortion in pigs 
 
(porcine  reproductive  and  respiratory  syndrome  virus,  PRRSV)  or  a  lethal haemorrhagic 
 
disease  in  non-human  primates  (simian  haemorrhagic  fever  virus,  SHFV)  (22).  The 
 
Coronavirinae  subfamily  of  the  Coronaviridae  includes  several  pathogens  of   mammals 
 
(Feline  coronavirus;  transmissible  gastroenteritis  virus;  Equine  coronavirus,  to  mention a 
 
few),  birds andfish,  and has  provided  a  steady supply of emerging  threats to  human health 
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over the past 15 years, including Severe Acute Respiratory Syndrome (SARS) and Middle- 
 
Eastern Respiratory Syndrome (MERS) (23). The members of the second subfamily of the 
 
Coronaviridae,  Torovirinae,  have  so  far  not  generated  similar  threats.  They  include 
 
bafiniviruses, which infect ray-finned fish and induce renal tubular necrosis and necrotising 
 
hepatitis (24), and toroviruses, which infect mammals (including humans, cattle, horses,    and 
 
pigs) (10, 11, 25–27). Toroviruses have a tropism for epithelial cells, of both the respiratory 
 
and alimentary tract (28–30); in cattle, an association with pneumonia has been reported   (30, 
 
31). Toroviruses exhibit a unique morphology, the viral particles are kidney- and/or rod- 
 
shaped,  with  a  tubular,  torus-shaped  ribonucleoprotein  (RNP)  enveloped  by  a membrane 
 
decorated with spikes composed of S protein (32). The RNP comprises the nucleoprotein    (N 
 
protein) and the ssRNA+ genome (33, 34). 
 
In 2014, a Swiss breeder submitted two adult green tree pythons for diagnostic post mortem 
 
examination. Both animals had died with signs of a “mucinous” pneumonia. In the   following 
 
year, the same breeder submitted another two individuals. These, as well as a further five 
 
green tree pythons from three additional breeders, all exhibited similar pathological   findings. 
 
In 2016, additional cases were observed, involving two more breeding collections. As all 
 
routine  diagnostic  tests undertaken  failed  to  identify potential  causative viruses  or specific 
 
bacterial  agents,  we  initiated  an  investigation  into  the  cause  of  this  apparently emerging 
 
disease of green tree pythons. 
 
9 
 
 
Material and Methods 
Animals. The study was performed on sixteen green tree pythons (Morelia viridis) from six 
 
breeding collections in Switzerland and one collection in Germany (Table 1). The  collections 
 
varied in both size (i.e. number of breeding animals) and species range, from a single snake 
 
up to a collection of 50 snakes of various species.  
 
All  animals  were  submitted  to  the  Institute  of  Veterinary  Pathology,  Vetsuisse  Faculty, 
 
University of Zurich, for diagnostic purposes. Fifteen snakes had died spontaneously, one was 
 
euthanized  following  an  ASPA  (Animals  Scientific  Procedures  Act  1986)  schedule       1 
 
(appropriate methods of humane killing,  
 
http://www.legislation.gov.uk/ukpga/1986/14/schedule/1)  procedure.  In  each  case, a full  
 
diagnostic post mortem examination was performed with owner’s consent. For these  
 
diagnostic-motivated necropsies, no ethical permission is required at the University of Zurich. 
 
The initial study population is represented by nine snakes, of which four (A1-A4) were   from 
 
one breeder (A), each two from a second and third breeder (B1, B2 and C1, C2), and one (D1) 
 
from a  fourth  breeder (Table  1A). These  animals  were submitted between  September 2014 
 
and  November  2015.  After  completion  of  the  next-generation  sequencing  (NGS)   study, 
 
another seven snakes were submitted (E1, F1, G1-G5) by another three breeders (E, F, G). All 
 
initial and another three snakes of the second cohort exhibited one common gross feature:  the 
 
airways contained a variable amount of mucoid material which was most abundant in the 
 
faveolar lumen (Table 1A). The remaining four snakes (G2-G5) did not show any changes   in 
 
the airways or lungs (Table 1B) and later served as controls. 
 
Sample collection and screening for infectious agents. During post mortem examinations 
 
samples from all organs were collected and fixed in 10% buffered formalin for histological 
 
examination. Additional samples from brain, lung, liver, and kidney were stored at -80 °C  for 
 
further analysis. Also, lung samples from the freshly euthanized snake (A2) and from two 
 
snakes  that  were  necropsied  within  a  few  hours  after  death  (B1,  D1)  were  fixed        in 
 
glutaraldehyde/paraformaldehyde and processed for transmission electron microscopy (TEM) 
 
as described (35). 
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Prior to performing NGS, six of the initial cases were screened for infectious agents: bacterial 
 
cultivation was attempted from the lungs of three snakes (A1, A3, D1) at the Institute of 
 
Veterinary Bacteriology, Vetsuisse Faculty, University of Zurich; and lung samples from 
 
another three snakes (B1, B2, C1) were submitted to a commercial lab (LABOKLIN, Basel, 
 
Switzerland) for virus diagnostics (reovirus, paramyxovirus, Sunshine virus, nidovirus) (Table 
 
 1). 
 
Virus isolation  and ultrastructural  characterisation. Primary tissue cultures of     Morelia 
 
viridis were established as described (35), using brain and liver material from a foetus (from a 
 
clutch of B1 and B2). The tissue was trimmed into blocks (1 mm) and suspended in 5 ml of 
 
minimal  essential  medium  (MEM,  ThermoFisher,  Scientific,  GIBCO)  supplemented with 
 
HEPES (25 mM), 10% fetal bovine serum (FBS; Biochrom), Gentamycin (0.05 mg/ml), L- 
 
Glutamine  (2  mM,  Biochrom),  10%  Tryptose Phosphate-Broth  (DIFCO),  and  20 µl α-D- 
 
Glucose (90 g/l PBS) in sterile cell culture dishes (5 cm in diameter), and incubated at 30   °C 
 
and  5%  CO2.  Primary  Boa  constrictor  lung  (V/4Lu)  and  brain  (V/4Br)  cell  lines   were 
 
established similarly as described above. 
 
Cell cultures were used for inoculations at passage 8-15 (M. viridis cell lines), 30-35 for 
 
V/4Lu and V/4Br. Briefly, after initial trimming of lungs into blocks (>1 mm) the pieces were 
 
mechanically homogenized in 1 ml of Trypsin-EDTA solution (0.25%, Gibco, Thermo Fisher 
 
Scientific), the cell debris pelleted by centrifugation (5 min at 1,000 x g), and the remaining 
 
supernatant was diluted in 5 ml of MEM supplemented with 25 mM HEPES (Thermo   Fisher 
 
Scientific) and 15% FBS (Biochrom), and 0.45 µm filtered. One ml of the filtered lung 
 
homogenate further diluted 1:10 in growth medium was used to inoculate 75-cm
2  
flasks of 
 
both brain and liver cells. The medium was changed at 1-2 day intervals until most cells 
 
detached or died. The supernatants were frozen at -20 °C, pooled, and 0.45 µm filtered.    The 
 
cleared supernatant was loaded onto a cushion of 30% (w/v) sucrose in PBS, concentrated   at 
 
100,000 g for 2 h at 4 °C and solubilized in PBS. For protection, protease inhibitor   (Protease 
 
inhibitor   cocktail   tablets   complete,   Mini,   EDTA-free,   Roche   Diagnostics, Mannheim 
 
11 
 
Germany) was added to the supernatant. For negative staining, samples were adsorbed to 
 
carbon-coated   parlodion   films   mounted   on   300   mesh/inch   copper   grids   (EMS, Fort 
 
Washington,  PA,  USA)  for  10  min,  washed  once  with  H2O,  and  stained  with  2% 
 
phosphotungstic acid (PTA), pH 7.0 (Aldrich, Steinheim, Germany) for 1 min. Specimens 
 
were  analyzed  in  a  transmission  electron  microscope  (CM12,  Philips,  Eindhoven,     The 
 
Netherlands) equipped with a CCD camera (Ultrascan 1000, Gatan, Pleasanton, CA, USA)  at 
 
an acceleration voltage of 100 kV. 
 
M. viridis brain and liver cells were harvested at 3, 4, and 5 days post infection (dpi) and 
 
pelleted by centrifugation at 5,000 rpm for 5 min at room temperature (Eppendorf   centrifuge 
 
5415C,  NIST).  The  pellets  were  fixed  with  2.5%  glutaraldehyde  in  PBS  (pH  7.4),  and 
 
routinely resin embedded for TEM (35). To obtain a retrovirus-free virus preparation, the 
 
supernatant collected from M. viridis liver cell cultures inoculated with lung homogenate  was 
 
used to inoculate a B. constrictor kidney cell line I/1Ki (35). Supernatant was collected   from 
 
the infected I/1Ki cells at two day intervals until 8 dpi. The supernatants were filtered through 
 
a 0.45 µm filter, pooled, aliquoted, and stored at -80 °C. 
 
 
 
Next-generation sequencing (NGS). RNA was isolated from the lungs of three diseased 
 
snakes (animals A2, B1, D1, Table 1) with TRIzol® reagent (Life Technologies) according to 
 
the manufacturer’s protocol, using 5 g of RNA grade glycogen (ThermoFisher Scientific)  as 
 
carrier. The RNA samples were initially treated with DNAse I (Fermentas), followed by re- 
 
purification with the GeneJET RNA purification kit (Thermo Fisher Scientific). Ribo-Zero 
 
Gold   rRNA   Removal   Kit   for   Epidemiology   (Illumina)   was   used   according   to  the 
 
manufacturer’s protocol to further clean the RNA. In the case of virus sequencing from cell 
 
culture  supernatants,  the  RNA  isolation  was  done  using  QIAamp  Viral  RNA  Mini   Kit 
 
(QIAGEN) following the manufacturer’s protocol without addition of carrier RNA. For  RNA 
 
isolated  from  cell  culture  supernatants,  the  rRNA  was  removed  with  NEBNext     rRNA 
 
Depletion  Kit  (New  England  Biolabs).  The  indexing  and  NGS  library  preparation    was 
 
accomplished with the NEBNext Ultra RNA Library Preparation Kit (New England   Biolabs) 
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according to the manufacturer’s protocol. The libraries were quantified using the NEBNext 
 
Library Quant Kit for Illumina (New England Biolabs). Pooled libraries were sequenced on 
 
an Illumina MiSeq (Illumina) using the MiSeq Reagent Kit v3 (Illumina), with 291-bp (for 
 
lung samples) and 300-bp (for RNA isolated from cell culture supernatant) reads from both 
 
ends (paired-end). De novo sequence assembly was performed after removing reads matching 
 
to the host genome, both with  MIRA version 4.9.5.    (http://mira-assembler.sourceforge.net/) 
 
on CSC (IT Center for Science Ltd., Finland) Taito supercluster. The generated contiguous 
 
sequences (contigs) from the lung sample run were initially screened by nucleotide BLAST 
 
(blastn, at https://blast.ncbi.nlm.nih.gov/Blast.cgi) and several contigs matching     ball python 
 
nidovirus (BPNV; NCBI Reference Sequence NC_024709.1) and Python nidovirus (PNV; 
 
GenBank accession KJ935003.1) were identified. In attempt to obtain full-length genome  the 
 
contigs were mapped to BPNV and PNV genomes using the BWA-SW tool      (36) in Unipro 
 
UGENE  (37).  However,  contig  with  almost  full-length  genome  for  a  novel      nidovirus 
 
subsequently named “Morelia viridis nidovirus (MVNV)” was obtained via de novo assembly 
 
from RNA isolated from cell culture supernatant. The genome open reading frames, ORFs, 
 
were detected using Unipro UGENE. The contig coverage was determined using Bowtie2 
 
reference alignment of the entire NGS data in Unipro UGENE. 
 
Phylogenetic analysis and bioinformatics. Since Blastn search of the contig obtained by   de 
 
novo assembly from purified virus material suggested that python nidoviruses (BPNV,   PNV, 
 
a  proposed  new  genus  in  the  Torovirinae  sub-family        of  nidoviruses)  were  the  most 
 
homologous  group  to  MVNV,  representative  sequences  of  this  sub-family  (i.e.      genus 
 
Torovirus, Bafinivirus and python nidoviruses) were downloaded from the GenBank. The 
 
amino  acid  sequences  of  the  conserved  ORF1b  were  aligned  using  ClustalW   algorithm 
 
implemented  in  MEGA  version  6.06  (38)  followed  by  manual  refinement.  The   best-fit 
 
substitution model was sought using maximum likelihood method implemented in MEGA 
 
6.06. Phylogenetic trees were constructed using the Bayesian Monte Carlo Markov Chain 
 
(MCMC) method implemented in BEAST version 1.8.0 (39). The analyses were performed 
 
with LG+G+I model of substitution, strict clock and constant size demographic model. The 
 
Bayesian analyses were run for 10 million states and sampled every 1000 states. The analyses 
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were carried out on CSC – IT Center for Science Ltd. (Espoo, Finland). Posterior probabilities 
 
were calculated with a burn-in of 1 million states and checked for convergence using Tracer 
 
version 1.6 (40). The mfold Web Server (available at http://unafold.rna.albany.edu/?q=mfold) 
 
was  utilized for determining the  RNA folding  (41)  around the  ribosomal  frameshift  signal 
 
(RFS). Unipro UGENE (37) was utilized for nucleotide alignments (MUSCLE (42)) around 
 
the RFS. HMMER: biosequence analysis using profile hidden Markov models (available at 
 
http://hmmer.org/, (43) was used to identify conserved domains in the identified ORFs. 
 
Quantitative  reverse  transcription-polymerase  chain  reaction  (qRT-PCR).  RNA  was 
 
extracted from lung tissue samples with the TRIzol® reagent (Life Technologies) utilizing 
 
mechanical homogenization with a MagNA Lyser (Roche). After addition of chloroform   and 
 
separation of the RNA-containing phase by centrifugation (15 min, 12,000 x g, 4°C) the RNA 
 
was  purified  with  the  QiaGEN  RNeasy  Mini  Kit  (Qiagen)  following  the manufacturer’s 
 
protocol for RNA clean up. 
 
The  amount  of  RNA  in  the  samples  was  measured  by  Nanodrop  2000c  (Thermo Fisher 
 
Scientific),  and   the   samples   were   subsequently   diluted  with   RNase-free   water   to  a 
 
concentration of 150 ng/µl to allow comparative assessment. 
 
A  Taqman  qRT-PCR  assay  was  set  up  using  the  following  primers  (Microsynth     AG, 
 
Switzerland): Nido-fwd, 5´-AGTCATCTGTCTCGACCACCT-3´ and Nido-rev, 5´- 
 
ACATGTAGAGCACTTTGACTGGTT-3´.  The  sequence  for  the  probe  (Microsynth  AG, 
 
Switzerland) was: Nido-probe, FAM-CGACAACTGGGTCATCAGACGC-TAMRA. 
 
The qRT-PCR was performed on an Applied Biosystems 7500 fast Real-Time PCR system 
 
using 96-well plates. The reaction volume (25 µl) consisted of 12.5 µl of One step   qRT-PCR 
 
MasterMix (Eurogentec), each 1 µl of forward and reverse primer (10 M), 1 µl of probe  (10 
 
M), 0.125 µl of reverse transcriptase (Euroscript RT and RNase Inhibitor Mix,  Eurogentec), 
 
5 µl (750 ng) of  template RNA, and  4.5 µl of DEPC-treated H2O. 
 
The qRT-PCR was set up with the following cycling conditions: 1) 30 min at 48 °C, 2) 10 
 
min at 95 °C, 3) 15 s at 95 °C, and 4) 1 min at 60 °C, 40 cycles between steps 3 and 4. The 
 
data was collected during step 4 of the RT-PCR programme. 
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Recombinant  protein  expression  and  generation  of  anti-MVNV  nucleoprotein       (N 
 
protein) antiserum. To identify the ORF for the N protein gene in the genome of the novel 
 
virus  isolate,  the  de  novo  assembled  genome  was  aligned  with  BPNV  (NCBI Reference 
 
Sequence   NC_024709.1)   and   PNV   (GenBank   accession   KJ935003.1)   genomes using 
 
MUSCLE (42) in Unipro UGENE (37). The N protein coding region was obtained from 
 
cDNA transcribed with random primers using RNA isolated from supernatants of cultured 
 
cells inoculated with lung tissue homogenate (see above). The cDNA transcription was   done 
 
using RevertAid Transcriptase (ThermoFisher    Scientific) following the protocol for random 
 
hexamer amplification. The PCR amplification of the whole N protein coding region was 
 
done with primers designed according to the Champion pET Directional TOPO Expression 
 
Kit’s manual (ThermoFisher Scientific) using Phusion Flash High-Fidelity PCR Master    Mix 
 
(ThermoFisher Scientific). The PCR product was purified from agarose gel using GeneJET 
 
Gel Extraction Kit (ThermoFisher Scientific) and ligated to pET101/D-TOPO vector with   N- 
 
terminal   V5-epitope   and   His-tags   (ThermoFisher   Scientific).   The   ligated   vector was 
 
transformed to One Shot TOP10 Competent Cells (ThermoFisher Scientific) and clones   with 
 
the desired insert were screened by plating on Luria Broth (LB) agar plates with 100 g/ml 
 
ampicillin. Individual colonies were grown in 5 ml of LB supplemented with 100 g/ml 
 
ampicillin overnight and the plasmids purified using the GeneJET Plasmid Miniprep Kit 
 
 (ThermoFisher Scientific) following the manufacturer’s recommendation. The plasmids  were 
 
sequenced  (Microsynth  AG,  Switzerland),  using  T7  forward  and  reverse  primers.  The N 
 
protein containing plasmid was transformed into BL21 Star (DE3) One Shot Chemically 
 
Competent  E.  coli  (ThermoFisher  Scientific),  and  protein  expression  was  done  in     LB 
 
supplemented with 100 g/ml carbenicillin (Sigma-Aldrich) and 1% glucose (Sigma-Aldrich) 
 
according to the manufacturer’s recommendation.  The recombinant  N protein  expressed   in 
 
inclusion  bodies  was  purified  using  Chelating  Sepharose  Fast  Flow  (GE  Healthcare Life 
 
Sciences) with cobalt as the immobilized metal ion and 8M urea in all buffers. The protein  in 
 
the elution buffer (50 mM Tris, 500 mM NaCl, 300 mM imidazole, 8M Urea, pH 7.5) was 
 
concentrated  using  a  10  kDa  cut  off  Amicon  Ultra-15  Centrifugal  Filter  Unit       (EMD 
 
Millipore), and buffer exchange (to 25 mM Tris, 75 mM NaCl, pH 7.5) was achieved by 
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decreasing the urea concentration slowly using Slide-A-Lyzer    Dialysis Cassette 3.5 MWCO 
 
(ThermoFisher Scientific). The purified recombinant protein was used to immunize a rabbit 
 
applying the following scheme: initial immunization (day 0), first booster (day 7), second 
 
booster  (day  14),  third  booster  (day  42),  and  final  bleeding  (day  49)  (BioGenes GmbH, 
 
Berlin, Germany). The generated antiserum was cleaned by affinity purification similarly to 
 
previous  descriptions  (44,  45).  Briefly,  500  g  of  purified  recombinant  N  protein    was 
 
dialyzed  in  PBS  followed  by  coupling  to  CnBr-activated  Sepharose  4B  (GE Healthcare) 
 
following   manufacturer’s   protocol.   The   affinity   matrix   was   packed   into   Econo-Pac 
 
Chromatography columns (Bio-Rad) and antiserum was passed through the column by gravity 
 
flow. After washing with several column volumes of PBS, the bound antibodies were eluted 
 
with 0.1M glycine (pH 2.5) and the fractions were neutralized by addition of 1M Tris, pH 8.5. 
 
The affinity purified antibody was dialyzed against PBS, and concentrated using 10 kDa cut 
 
off Amicon Ultra-15 Centrifugal Filter Unit (EMD Millipore). The purified antibody was 
 
mixed with glycerol (50%) and stored in aliquots at -20 °C. 
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Immunofluorescence staining, qRT-PCR of cell culture supernatants, and estimation   of 
 
virus titer. 
 
For immunofluorescence staining M. viridis (brain) and B. constrictor (kidney, lung, brain) 
 
cells were detached by trypsin, washed with growth medium, and seeded on glass bottom  24- 
 
well plates (IBL, Gerasdorf, Austria). The attached cells were inoculated by incubation with 
 
250 l of 1/10 diluted (in growth medium) MVNV isolated on I/1Ki. After 1 h incubation at 
 
30 °C the cells were washed twice with supplemented growth medium, and finally 1 ml of 
 
supplemented growth medium was added to each well. For each cell line three wells were 
 
inoculated  with  MVNV  and  three  wells  were  mock-infected  with  supplemented   growth 
 
medium. At 3 dpi the cells were fixed by replacing the supplemented growth medium with 
 
4% EM-grade paraformaldehyde in PBS followed by 15 min incubation at RT. After  fixation 
 
the cells were washed once with PBS, permeabilised (0.25% Triton X-100 and 3% BSA in 
 
PBS), and left in PBS until staining. The replicate wells (3 replicates of MVNV and mock- 
 
infected for each cell line) were incubated with anti-MVNV NP antibody at 1:1,000,  1:2,000, 
 
or 1:4,000 dilution (in PBS) for 1 h at RT, washed 5 times with PBS, incubated 45 min at  RT 
 
with   1:1000  PBS-diluted   AlexaFluor   594  labelled  goat  anti-rabbit  secondary   antibody 
 
(Invitrogen), washed 4 times with PBS, incubated for 1 min with DAPI in PBS, washed twice 
 
with dH2O, air dried, and coverslipped with FluoreGuard mounting medium (Biosystems, 
 
Switzerland).  The  images  of  MVNV-  and  mock-infected  cells  were  taken  at  a  400     x 
 
magnification with a Nikon Eclipse Ti-U inverted microscope with    NIS Advanced Research 
 
software, 1:2,000 diluted anti-MVNV NP antiserum yielded the best signal to noise ratio. 
 
For monitoring virus production cell culture supernatant was collected at 0, 1, 2, and 3 dpi. At 
 
each time point 47 l from each well was collected and samples from replicate wells were 
 
pooled to make ~140 l. The samples were stored frozen at -20 °C prior to RNA isolation 
 
with QIAamp Viral RNA Mini Kit (QIAGEN). The cell culture supernatants were analysed 
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by qRT-PCR in duplicates, and the relative amount of virus RNA (as compared to 0 dpi) at 
 
each time point was determined using 2
-ΔCt
. 
 
To estimate the virus titer in MVNV stock isolated on B. constrictor kidney cell line   (I/1Ki), 
 
M.  viridis  brain  cells  were  trypsinised,  washed  with  supplemented  growth  medium, and 
 
seeded onto 96-well tissue culture plate (TPP, Switzerland) in 135 l of supplemented growth 
 
medium per well. A serial 10-fold dilution of MVNV stock was prepared reaching 1:10
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dilution, and 15 l of each dilution was pipetted on 12 parallel wells. The plate was incubated 
 
for 5 d at 30 °C (until a clear cytopathic effect, CPE, was seen in all wells inoculated with 
 
MVNV dilutions). 
 
Histology, immunohistology and RNA-in situ hybridisation. Formalin-fixed tissue samples 
 
were trimmed and routinely paraffin wax embedded. Sections (4-5 μm) were prepared and 
 
stained with haematoxylin and eosin (HE) and the PAS/Alcian Blue stain for the evaluation of 
 
mucus-producing  cells,  or  used  for  immunohistology  (IH)  and  RNA-in  situ hybridisation 
 
(RNA-ISH) (performed on the lungs of all affected snakes, plus all major organs/tissues of 
 
five affected animals (B1, B2, A4, G1, E1) and one healthy individual (G5)). 
 
IH was performed to demonstrate nidovirus NP in tissue sections, using the custom made 
 
rabbit polyclonal antibody (see above). The EnVision HRP detection system (Dako, Baar, 
 
Switzerland)  was  applied.  After  deparaffination,  sections  were  incubated  in   peroxidase- 
 
blocking solution (Dako) for 10 min at room temperature to block any endogenous peroxidase 
 
activity, followed by incubation with the primary antibody (anti-MVNV N protein; diluted 
 
1:1,000 in Dako dilution buffer) for 12-15 h at 4°C. This was followed by incubation with 
 
Envision + System HRP Rabbit Antibody (Dako) according to the manufacturer’s protocol. 
 
The  reaction  was  visualised  with  diaminobenzidintetrahydrochloride  (DAB),  followed by 
 
counterstaining  with  haematoxylin.  The  sections  underwent  a  TBS-Tween  wash     (Tris- 
 
buffered saline solution containing Tween 20, pH 7.6) for 10 min between each incubation 
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step. A formalin-fixed, paraffin embedded cell pellet prepared from the infected cell   cultures 
 
served as positive control. Consecutive sections incubated with the pre-immune serum instead 
 
of the specific primary antibody served as negative controls. 
 
Sections from lungs and trachea were also stained by IH for cytokeratins (clone PCK-26, 
 
Novus Biologicals) to highlight respiratory and epithelial cells, for cleaved caspase-3   (rabbit 
 
anti-human cleaved caspase-3 monoclonal antibody, Asp175, clone 5A1E; Cell Signaling 
 
Technology) to demonstrate apoptotic cells, and for proliferating cell nuclear antigen   (mouse 
 
anti-rat  PCNA,  clone  PC10;  Dako)  to  detect  proliferating  cells,  using  routine   protocols 
 
established for other species (46–48). Intestinal epithelium was used as a positive control   for 
 
all  three  detection  systems  after  cross  reactivity  of  the  antibodies  was  confirmed  by   a 
 
comparison  of  the  expression  pattern  in  the  python  with  those  seen  in  the     respective 
 
mammalian tissues. 
 
For RNA-ISH, the RNAscope technology (Advanced Cell Diagnostics Inc., Newark, USA) 
 
was employed, using a set of 30 Z-oligoprobes (based on the MVNV genome) and   following 
 
the manufacturer’s instructions (49). DAB was used as the chromogen and haematoxylin    for 
 
counterstaining. A formalin-fixed, paraffin embedded pellet of virus infected cells served as 
 
positive control. DapB (the bacterial gene coding for dihydrodipicolinate reductase) was  used 
 
as a negative control. RNA preservation was confirmed by the detection of a housekeeping 
 
gene, ubiquitin C (UBC). 
 
Morphometry.  The  quantitative  assessment  of  the  observed  changes  in  the (respiratory) 
 
epithelium  was  undertaken  in  the  proximal,  bronchial  lung,  as  the  caudal  part  is    non- 
 
respiratory and taken up by the air sacs Three regions were defined in the proximal, bronchial 
 
lung, based on their epithelial cover and functions (Fig. 9; Fig. 2A): 1) The luminal part of the 
 
primary   trabeculae:   This   is  covered   by   multilayered   pseudostratified “bronchial-type” 
 
epithelium, dominated by ciliated cells, with few secretory and goblet cells, supported by a 
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thick smooth muscle layer (i.e. myoelastic bundles) (50, 51). 2) Middle level and 3) base of 
 
the faveolae: The faveolae are covered by a single-layered epithelium similar to that in the 
 
mammalian lung (“gas exchange epithelium”),       dominated by flat type I pneumocytes with 
thin,  cytoplasmic extensions that cover the pulmonary capillaries and contain micropinocytotic 
 vesicles (52). Between the capillaries lie the surfactant producing type II pneumocytes,  
cuboidal cells with short microvilli that contain lamellar bodies and   numerous  
micropinocytotic  vesicles  (53). In  addition, so-called “secretory  cells” containing  secretory 
granules have been described (50). 
 
HE- and cytokeratin-stained cross-sections of the lungs were examined and photographed 
 
using a light microscope (Eclipse Ni-U, Nikon Corp.), and the images analysed with the 
 
associated imaging software (NIS-Elements AR, Nikon Corp.). 
 
The average total height of the epithelial layer was determined in each of the three regions. 
 
For  this  purpose,  the  distance  between  the  apical  epithelial  cell  border  and  the      basal 
 
membrane was measured at each 10 points over three 300 µm wide epithelial segments in 
 
each region in the cytokeratin stained section at a 200-fold magnification (Fig. 9B, D, E).  For 
 
each  location,  the  average  value  obtained  for  each  of  the  three  segments  was  used    to 
 
determine the average height. 
 
As we also observed an apparent increase in the cell layers of the generally multilayered 
 
epithelium in several diseased animals in region 1 and saw evidence of increased cellularity in 
 
the other two regions, we counted the total number of epithelial cell nuclei in each three 200 
 
µm segments in all three regions in the cytokeratin stained section at a 400-fold magnification 
 
 (Fig. 9C). 
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Statistical Analysis. Statistical analyses were performed to assess the epithelial thickness and 
 
cellularity, using SPSS Statistics 17.0.0 (IBM), a 0.05 significance level was utilized for all 
 
calculations. A Mann-Whitney U test for independent samples (t-test) was applied to compare 
 
lung parameters between non-infected and infected snakes. 
 
Accession number(s). 
 
MVNV genome is available in GenBank under accession number MF351889 and the raw 
 
NGS data is available at http://www.ncbi.nlm.nih.gov/biosample/7248312. 
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Results 
 
Animals, clinical signs, macroscopical and histological features and results of   screening 
 
for infectious agents. In 2014-2016, multiple Morelia viridis affected by a similar disease 
 
arrived for post mortem examination: four from one breeder (A1 and A2 in 2014, A3 and   A4 
 
in 2015), five from three additional breeders (B1, B2, C1, C2, and D1 in 2015), and three 
 
animals from three additional breeding collections (E1, F1, and G1 in 2016). Of these 12 
 
snakes, four had died suddenly without any obvious clinical signs and seven had exhibited 
 
respiratory distress and expulsion of mucus for a period of a few hours to more than one week 
 
before death; for one animal no clinical history was available. All animals were adult, ranging 
 
from 1 to 8 years of age (Table 1A). Six snakes were female, six male. Upon gross post 
 
mortem examination all snakes exhibited a variable amount of mucoid material in the airways 
 
and, most abundant, in the faveolar spaces of the lung. In some animals, the entire trachea, the 
 
internal choanae and the caudal air sacs were obliterated by mucoid material (Fig. 1), and  the 
 
lung parenchyma appeared thickened. The histological examination revealed a variable degree 
 
of   epithelial   thickening   in   trachea    and   lung and   a   mild   to   moderate   interstitial  
 
lymphoplasmacellular and heterophilic infiltration of the lung parenchyma (Fig. 2). In one  
 
animal  (E1)  a  moderate  multifocal  granulomatous-necrotising   nephritis  was   additionally  
 
observed. The four control snakes (G2-6), i.e. animals that had been euthanized due to non-  
 
respiratory diseases (Table 1B), did not exhibit similar gross and/or histological changes (Fig.2). 
 
We suspected an infectious cause and had routine bacteriological examinations performed  on 
 
the lungs of selected snakes from the 2014 and 2015 cohort (A1, A3, D1). This only yielded a 
 
non-specific bacterial flora (i.e. no primary pathogens; Pseudomonas aeruginosa, Proteus sp., 
 
Citrobacter   braakii,   Achromobacter   xylosoxidans,   Stenotrophomonas   maltophilia    and 
 
Providencia rettgeri). A further three animals, from the 2015 cohort (B1, B2, C1) were then 
 
screened  in  a  commercial  laboratory  for  a  range  of  potentially  pathogenic  viruses   (i.e. 
 
reovirus, paramyxovirus, Sunshine virus, nidovirus); these tests yielded negative results. 
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Virus isolation in tissue cultures. As the routine bacteriological and virological tests failed 
 
to identify a common denominator for the diseased snakes, we decided to attempt virus 
 
isolation. For this purpose we prepared primary cell cultures of green tree python fetal liver 
 
and brain (Fig. 3A). After four passages the cells began to proliferate more rapidly and we 
 
could expand the cultures enough to attempt isolation of the unknown pathogen. When we 
 
used  lung  homogenates  from  diseased  snakes  (Table  1A)  to  inoculate  both  cultures, we 
 
observed the first evidence of a cytopathic effect (enlargement, rounding, and cytoplasmic 
 
vacuolisation of cells) and loss of adherence (Fig. 3B) at approximately 3 dpi. At 6 dpi almost 
 
the entire monolayer was affected and most cells had rounded and/or detached. (Fig. 3C). The 
 
ultrastructural examination of a cell pellet prepared from the cultures at 1 dpi identified 
 
abundant tubular viral structures arranged in stacks within the cytoplasm of infected cells 
 
(Fig. 3D, E). We concentrated the supernatants of the infected cells by ultracentrifugation and 
 
examined the pelleted material by TEM under negative staining. TEM analysis   demonstrated 
 
rod-  and  kidney-shaped virions  of approximately 120 nm  length  (Fig. 3F), consistent   with 
 
torovirus particles (29, 54)
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Identification of  nidovirus by NGS  and confirmation of  the  findings  by  real-time RT- 
 
PCR.  In  parallel  to  our  attempts  at  virus  isolation,  we  decided  to  employ  NGS  for the 
 
identification  of  the  causative  agent(s)  for  the  pneumonia.  We  isolated  RNA  from lung 
 
homogenates of three animals (A2, B1, D1) and performed RNA sequencing.  For two snakes 
 
(B1,  D1)  only  contigs  matching  bacterial  genomes  were  identified.  We  interpreted these 
 
bacterial sequences to most likely represent either contamination during post mortem   sample 
 
collection or,  more  likely,  secondary bacterial  infection, as both  had  also  shown moderate 
 
diffuse heterophil infiltration in the lung. From the third snake (A2), however, we obtained   a 
 
single ~21.000 nt contig and several shorter contigs matching the previously identified   “Ball 
 
python nidovirus (BPNV)” and “Python nidovirus (PNV)” (~85% identical to both) (9, 8).   In 
 
total we obtained ~28.000 nt (~75-80%) of the genome from the lung sample. In addition to 
 
the novel nidovirus isolate, we identified a contig matching endogenous retrovirus genes  with 
 
very high coverage, which we describe in a separate report (Hepojoki et al., in preparation). 
 
However,  the  retrovirus  was  also  present  in  the  supernatants  of  M.  viridis  cell  cultures 
 
inoculated with lung homogenate. We decided to attempt producing a nidovirus preparation 
 
devoid of the contaminating retrovirus. To do this we inoculated boid kidney cells with 
 
supernatant   collected   from   Morelia   viridis   liver   cell   culture   inoculated   with     lung 
 
homogenates,  since  Huder  et  al.  previously  reported  species-restricted  growth  of  an 
 
endogenous python retrovirus (55). Using this approach we obtained a pure nidovirus   isolate 
 
as  confirmed  by  retrovirus-specific  RT-PCR.  We  then  performed  end-point  titration    to 
 
quantify the number  of  infectious  units  in the MVNV stock on  M.  viridis  brain cells,   and 
 
could  detect  2.25*10
10   
focus  forming  units  per  1  ml  of  cell  culture  supernatant.    RNA 
 
extracted  from  the  pure  nidovirus  preparation  was  subjected  to  another  NGS  run, which 
 
yielded  almost  a  full-length  genome  in  a  single  contig.  We  then  performed  a  reference 
 
assembly using BPNV as the template to recover the missing (some 150 nt in total) genome 
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ends for the novel virus, Morelia viridis nidovirus (MVNV). The overall genome structure  of 
 
MVNV (GenBank accession number MF351889) was similar to that of BPNV and PNV (Fig. 
 
4A).  The identified contig  contains eight partially overlapping  open reading  frames,  ORFs, 
 
flanked by 5’UTR (~650 nt) and 3’UTR (~920 nt). We used HMMER3 to look for  functional 
 
domains in the detected ORFs, and collected domains detected at high probability in Table  2. 
 
We also identified a putative ribosomal frameshift signal (RFS) sequence near the end of 
 
ORF1a. To further study the RFS, we aligned the sequences of other nidoviruses identified  in 
 
snakes around the RFS and used mFOLD to predict the structure around this region in MVNV 
 
genome (Fig. 4B). The NGS data (raw data available at 
 
http://www.ncbi.nlm.nih.gov/biosample/7248312), coverage for MVNV genome is shown   in 
 
Fig. 4C. The nt and amino acid identities between the novel nidovirus isolate and other 
 
python nidoviruses are indicated in Table 3. 
 
We then tested whether the isolated MVNV could infect other cell lines. For this purpose   we 
 
selected brain, kidney and lung cell lines of B. constrictor, and used M. viridis brain cells as 
 
the positive control. We also designed a Taqman real-time RT-PCR to be able to quantify and 
 
monitor nidovirus RNA in cell culture supernatants and lung tissue samples of the diseased 
 
snakes. Analysis of the cell culture supernatants collected from different cell lines   inoculated 
 
with MVNV showed clear amplification in B. constrictor kidney and lung cells (Fig. 4D). The 
 
cytopathic  effect  on  M.  viridis  brain  cells  was  extremely  severe,  and  therefore    similar 
 
quantification could not be performed. The infected cells were stained using anti-MVNV   NP 
 
antiserum at 3 dpi and all cell lines, except B. constrictor brain (only few infected cells   were 
 
detected), showed to be extremely permissive for MVNV (Fig. 5). 
 
As ORF1b is the most conserved ORF among nidoviruses (17), we selected this region for the 
 
phylogenetic  analysis.  The  phylogenetic  tree  suggests  that  MVNV  forms  anoutgroup   to 
 
BPNV and PNV (Fig. 6). Further, the python nidoviruses cluster together with Shingleback 
 
nidovirus (KX184715) (56), Xinzhou nematode virus 6 (KX883637), Xinzhou toro-like  virus 
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(NC_033700), and bovine nidovirus (NC_027199) (31). Consistent with the previous reports, 
 
these form a clade that is separate from both the genus Bafinivirus and the genus Torovirus 
 
 (Fig. 6). 
 
Finally, we used RNA isolated from cell cultures inoculated with lung homogenates of an 
 
infected snake as the positive and RNA isolated from a Boa constrictor as the negative 
 
control in the real-time RT-PCR. All diseased snakes were tested positive for nidovirus  RNA 
 
in  the  lungs.  In  contrast,  the  four  snakes  without  gross  and/or  histological  evidence  of 
 
pneumonia were negative. 
 
 
Nidoviruses are associated with pneumonia in M. viridis. The histological examination 
 
confirmed that all diseased snakes had suffered from a chronic pneumonia with epithelial 
 
thickening in trachea and lung (Fig. 2) and excess mucus in the lumen of lungs and airway. 
 
The inflammatory component was represented by mild to moderate multifocal interstitial 
 
infiltration of lymphocytes, plasma cells and/or heterophils (Fig. 2E). The mucus filling the 
 
faveolar  space  often  contained  heterophils  and  cell  debris.  In  three  of  the  nine tracheas 
 
examined, we also observed a variable degree of mixed infiltration (heterophils, macrophages, 
 
lymphocytes). Over its entire length, the lung epithelium exhibited numerous epithelial    cells 
 
that contained mucus as indicated by the PAS-Alcian Blue staining (Fig. 7A, C, E). In  region 
 
1,  at the trabeculae,  the mucus  containing  cells had  the ultrastructural  features  of secretory 
 
cells (50) (Fig. 7B). In regions 2 and 3 (faveolar epithelium), where the increase of these cells 
 
was most striking, they exhibited the morphology of type II pneumocytes (Fig. 7D, F) (51); 
 
their number varied in affected snakes and ranged from occasional patchy aggregates to 
 
diffuse lining of the entire faveolae, associated with an almost complete absence of type I 
 
pneumocytes (Fig. 2E). Ultrastructurally, these cells exhibited serous/mucous granules instead 
 
of the lamellar bodies that are characteristic for type II pneumocytes (Fig. 7B, D, F); they 
 
have recently been described as “transformed” type II pneumocytes (58). 
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Having detected nidoviral RNA in the affected lungs, we aimed to identify the viral target 
 
cells. For this purpose, we employed both RNA-ISH and IH. Viral RNA and antigen (N 
 
protein) were detected in the cytoplasm of the trabecular pseudostratified epithelium    (region 
 
1) and of both type I and type II pneumocytes lining the faveolar space (regions 2 and 3) in all 
 
affected snakes (Fig. 8A-D). Intact and degenerated cells shed into the mucus were found to 
 
be infected, and occasionally we also detected cell-free viral RNA and antigen (Fig. 8B). 
 
Infected cells varied in number between animals and in individual snakes also in different 
 
areas of the lung. In the hyperplastic epithelium of region 1, most cells exhibited a weak, 
 
focal cytoplasmic reaction, and only the superficial cell layer contained abundant viral antigen 
 
(Fig. 8B). The new type II pneumocytes    that seemed to progressively replace the type I cells 
 
exhibited a similarly weak focal reaction, whereas the fully differentiated pneumocytes   were 
 
strongly positive for viral antigen (Fig. 8C, D), suggesting more efficient virus replication. 
 
When examined, the trachea (n=9) and the nasopharyngeal epithelium (n=1) also exhibited 
 
infected, degenerating epithelial cells (Fig. 8E, F). Viral antigen was detected in few epithelial 
 
cells of the oesophagus in one animal with acute pneumonia (G1). Interestingly, viral  antigen 
 
was also detected cell-free and in a few macrophages in the focal    granulomatous-necrotising 
 
nephritis in another affected animal (E1). We did not detect viral RNA or antigen in other 
 
tissues ofthe infected snakes including stomach and intestines, or in the lungs of the control 
 
snakes (G2-6). 
 
We could demonstrate cytoplasmic accumulations of tubular structures, ranging from 150  nm 
 
to 250 nm in length in rare epithelial cells with the morphology of type II pneumocytes by 
 
ultrastructural examination (Fig. 8G). 
 
The epithelial thickening was the most striking feature in the lungs of the nidovirus-positive 
 
snakes. We therefore performed a more detailed histological examination in the attempt to 
 
identify the processes underlying this phenomenon. The multilayered epithelium covering  the 
 
trabeculae  (region  1)  displayed  increased  cellularity  with  an  increase  in  cell  layers  and 
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irregular arrangement, indicating hyperplasia (Fig. 2E). The epithelial hyperplasia extended to 
 
the upper respiratory tract and was also observed in the trachea, larynx and nasal cavity.   The 
 
mid and basal areas of the faveolae (regions 2 and 3), where the epithelium is unilayered, 
 
showed  nuclear  crowding  which  also  suggested  hyperplasia  (Fig.  2E).  The     thickening 
 
appeared to result from an increase in individual cell height, associated with a more columnar 
 
appearance of the cells (Fig. 2E, F). Additionally, we noted an increase in septal connective 
 
tissue (interstitial fibrosis). The described changes resulted in thickening of the septa and 
 
narrowing of the faveolar lumen (Fig. 2D). 
 
In the attempt to quantify the epithelial hyperplasia we measured the average total epithelial 
 
height in the three defined regions (Figs. 2 and 9) in all diseased, i.e. RT-PCR-positive 
 
animals in comparison to the RT-PCR-negative animals without pneumonia (controls). In   all 
 
locations, the epithelium was significantly (P <0.05 higher in the diseased animals than in  the 
 
control snakes (Fig. 10A; Table 4). Hyperplasia was confirmed in both lung (regions 1, 2  and 
 
3) and trachea, where the average number of nuclei in the epithelial layer was significantly 
 
higher in the diseased snakes (Fig 10B; Table 4). 
 
Epithelial hyperplasia was associated with increased proliferative activity, as up to 90% of 
 
epithelial cells in all lung regions and in the trachea were found to express PCNA in the 
 
diseased animals (Fig. 11A). Alongside this, a moderate number of epithelial cells were found 
 
to undergo apoptosis, based on cleaved caspase-3 staining (Fig. 11C). In comparison,   control 
 
animals exhibited rare PCNA-positive type II pneumocytes in all layers (Fig. 11B) as well   as 
 
scattered apoptotic (cleaved caspase-3 positive) type I and type II pneumocytes (Fig. 11D), 
 
likely representing the physiological turnover of the epithelium. 
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Discussion 
We initiated the present study by the urge to identify the causative agent for a fatal pneumonia 
 
observed in green tree pythons (Morelia viridis), characterised by the accumulation of mucoid 
 
material in the airways and a histologically notable thickening of the lung epithelium. NGS 
 
revealed the presence of a novel nidovirus, MVNV, which by phylogenetic analysis groups 
 
with toroviruses. RT-PCR, immunohistology and RNA-ISH served to confirm its   association 
 
with the disease and to identify the viral target cells, i.e. epithelial cells in airways and the 
 
luminal trabeculae, as well as the faveolar type I and II pneumocytes. We were able to  isolate 
 
and  grow  MVNV  in  both  M.  viridis  and  B.  constrictor  cell  cultures.  MVNV  induced a 
 
cytopathic effect both in vitro and in vivo. However, we also found nidovirus infection to 
 
associate with generalised hyperplasia of the airway and lung epithelium which exhibited a 
 
distinct proliferative activity and a degree of apoptotic cell death. Together these findings 
 
would suggest nidovirus infection to increase the turnover of the epithelium. The mucus 
 
accumulation  in  the  air  conducting  space  was  accompanied  by  a  significant  increase  in 
 
secretory epithelial cells at the trabeculae and in (transformed) type II pneumocytes in the 
 
faveolae, indicating increased mucus and/or surfactant production. 
 
These results indicate that MVNV infects and damages the differentiated respiratory and 
 
faveolar epithelium, but then persists and induces increased turnover of the infected  epithelial 
 
cells. The observed type II pneumocyte hyperplasia is obviously not specific to nidovirus 
 
infection in the python, since it has been described in snakes as a consequence of pneumocyte 
 
injury in a range of infectious diseases of viral, bacterial and mycotic nature (51, 58).  It might 
 
therefore   represent   an   exaggerated   regenerative   attempt.   Also   in   mammals   type   II 
 
pneumocyte hyperplasia is seen as part of a lung defense mechanism to various insults (59– 
 
61).   In   our   cases,   the   hyperplastic   epithelial   cells   exhibited   abundant   cytoplasmic 
 
serous/mucous granules instead of the lamellar bodies that represent surfactant (50). This 
 
suggests excess mucus and reduced surfactant production and release and would explain the 
 
clinical findings (50, 58). Previous studies have shown that the surfactant of snakes, due to its 
 
differing phospholipid composition, is likely less important for airway stabilisation, but rather 
 
functions as an anti-adherent (also known as an "anti-glue") factor and an anti-oedemic  factor 
 
in the faveolar space (62); its reduction could therefore have added to the respiratory   distress 
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observed in the affected snakes. 
 
Increased  turnover  and/or  hyperplasia  of  the  epithelium  has  been  described  for   several 
 
coronaviridal diseases, such as infectious bronchitis in chickens, Breda virus infection in 
 
calves, and coronavirus infection in rats (63–65). So far, however, the mechanisms underlying 
 
this process have not been explained. Members of the subfamily Torovirinae are also   known 
 
to induce epithelial cell apoptosis (54, 66, 67); however, though our findings point towards 
 
this, further studies are required to elucidate whether this also applies to MVNV and other 
 
snake nidoviruses. 
 
In our study, only fatal cases were examined. The pathological findings suggest that death 
 
was mainly due to impaired gas exchange as a consequence of the type I pneumocyte loss.   In 
 
the healthy snake lung, thin cytoplasmic extensions of the type I pneumocytes cover the 
 
capillary walls, forming the gas-blood barrier (50). Their replacement    by  mucus/surfactant- 
 
secreting type II pneumocytes with their excessive height due to the cell crowding is  unlikely 
 
to allow effective gas exchange. With an average thickness of 24.40 µm (region 2) and  17.43 
 
µm (region 3), the barrier was more than 1.7 x 10
4  
times thicker than the normal blood-gas 
 
barrier in the reptilian lung which ranges between 0.4 and 1 nm (50). 
 
Further anatomical peculiarities of the Morelia viridis (or in general boid snake) lung could 
 
have  contributed  to  the  fatal  outcome  of  the  disease  (51,  68–70).  Boidae  have  a   well- 
 
developed  right  lung  and a  rudimental  left  lung. The right lung  displays  two anatomically 
 
distinct  regions,  the  anterior  region,  which  contains  the  profusely  compartmented      gas 
 
exchange tissue, and the posterior saccular region, which is devoid of respiratory tissue and 
 
has therefore been referred to as “air sac” (71, 72). The combination of elongated lungs and 
 
caudal air sacs may contribute considerably to the outcome of the disease, as they create a 
 
 “cul-de-sac” that impairs removal of the mucus and thereby significantly reduces the air filled 
 
space and the gas exchange capacity. 
 
Though toroviruses mainly associate with enteric diseases, recent studies have shown that 
 
they can be both entero- and pneumotropic (31, 73, 74). New nidoviruses were recently 
 
identified in the lungs of cattle and wild shingleback lizards with pneumonia, though their 
 
direct association with disease has so far not been examined (31, 56). We found MVNV- 
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associated lesions almost exclusively in the airways and lung, similar to previous reports on 
 
nidovirus infections in other python species (8, 9, 15). The detection of viral RNA by PCR  in 
 
other tissues, such as liver, spleen, kidney and intestine, however, indicated that the viruses 
 
spread  systemically.  We  found  further  evidence  of  that,  and  of  its  pathogenicity,  as we 
 
detected nidovirus NP within a focal granulomatous-necrotising nephritis in one animal.    We 
 
also detected viral antigen in epithelial cells of the cranial oesophagus in one affected  animal; 
 
however, the oesophagus carries ciliated epithelium in M. viridis (data not shown), a feature 
 
also known for other snake species (75, 76); infection could therefore be due to an overspill 
 
from the trachea and nasal cavity. We did not detect viral antigen in any cells in stomach   and 
 
intestine, and neither did a previous study find viral RNA by ISH, suggesting that the   python 
 
nidoviruses are primarily respiratory (8). Spreading via the expelling of mucus from the  nasal 
 
cavity would be a likely route of transmission. 
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Figure Legends 
 
Figure 1: Gross findings in a green tree python (Morelia viridis) with nidovirus-associated 
 
proliferative pneumonia (animal E1). Both trachea (A) and lungs (B) are filled with  abundant 
 
mucoid material (arrows). H - heart. 
 
Figure  2:  Histological  findings  in  Morelia  viridis  with  nidovirus-associated proliferative 
 
pneumonia. A-C. Uninfected control case (animal G2). Representative photomicrographs of a 
 
healthy lung (cross section). Thin pulmonary septa form the faveolar spaces. At the luminal 
 
end,  the  septa  exhibit  bundles  of  smooth  muscle  cells  (myoelastic  bundles)  that     form 
 
contractile trabeculae. For detailed assessments, three regions (1, 2, 3) were identified. The 
 
trabeculae  are  covered  by  a   multilayered  pseudostratified  “bronchial-type”     epithelium, 
 
dominated by ciliated cells (B1, C1). In regions 2 (B2, C2) and 3 (B3, C3), the faveolae are 
 
covered by a single-layered “gas exchange epithelium” comprised of flat type I   pneumocytes 
 
(arrowheads); surfactant producing type II pneumocytes (arrows) are less abundant. D-F. 
 
Snake with nidovirus infection (animal B4). Representative photomicrograph of a diseased 
 
lung (cross section). In the entire lung, the epithelial layer is thickened due to hyperplasia. 
 
The faveolar space (3) is filled with proteinaceous material and the interstitium is    broadened 
 
due to a mixed inflammatory infiltrate (E1, 2). In region 1 (E1, F1), the pseudostratified 
 
epithelium covering the trabeculae exhibits increased cellularity with an increase in cell layers 
 
and  irregular  arrangement  (hyperplasia)  as  well  as  a  loss  of  cilia  and  several  apoptotic 
 
epithelia cells (arrowheads). In regions 2 (E2, F2) and 3 (E3, F3), type I pneumcytes are 
 
almost entirely replaced by large, columnar type II pneumocytes. A, B, D, E: HE stain; C,   F: 
 
IH for cytokeratin, haematoxylin counterstain. Bars = 100 µm (A, D) and 10 µm (B, C, E, F). 
 
Figure 3: Virus isolation in a primary Morelia viridis foetal brain cell culture. A.   Uninfected 
 
control cells. B, C. Cells after inoculation with lung homogenate from a diseased snake 
 
(animal C2). First evidence of a cytopathic effect is seen after 2 days (B), as enlargement, 
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rounding, and cytoplasmic vacuolisation as well as loss of adherence (arrows). After 6 days 
 
(C),  only  few  intact  cells  have  remained.  Most  cells  are  detached  and  necrotic.  D,   E. 
 
Ultramicrographs  of a  cell  pellet  prepared at  1 dpi.  There  are  abundant tubular  structures 
 
arranged in stacks within the cytoplasm of infected cells. F. Concentrated supernatant of the 
 
infected cells, negative staining. Rod- and kidney-shaped virions of approximately 120 nm 
 
length. Bar = 1 µm (D) and 100 nm (E). 
 
Figure  4.  Morelia  viridis  nidovirus,  MVNV,  genome  organization,  NGS  coverage,   and 
 
phylogenetic relationship to related viruses. A. A schematic representation of the untranslated 
 
regions  (UTRs)  and  open  reading  frames  (ORFs)  of  the  32,414  nt  ssRNA+  genome  of 
 
MVNV. B. Alignment around the ribosomal frameshift signal (RFS, indicated by an arrow  in 
 
the alignment and structure prediction) in nidoviruses identified in pythons with ORF1a   stop 
 
codon highlighted. A prediction for the RNA structure around the RFS in MVNV, the arrow 
 
highlights  a  difference  to  the  structure  described  by  Bodewes  et  al.  (8)  C.  The   contig 
 
coverage, y-axis shows the number of reads matching each nucleotide position (x-axis) of  the 
 
contig. Bowtie2 was used to map the reads to the contig generated by de novo assembly. D. 
 
Virus  growth  in  different  cell  lines.  Cell  culture  supernatant  of  the  indicated  cell   lines 
 
inoculated with MVNV was analyzed by qRT-PCR at the indicated time points. The fold 
 
increase indicates viral RNA increase in the cell culture supernatant as compared to the 
 
amount detected at 0 dpi. 
 
Figure 5. Immunofluorescence staining of M. viridis and B. constrictor cell lines with anti- 
 
MVNV NP antiserum at 1:2,000 dilution. MVNV- or mock-infected cells were stained at 3 
 
dpi, and recorded at 40x under inverted fluorescence microscope. Mock infected cells are 
 
shown on the right and MVNV infected cells on the left. DAPI is shown in blue and MVNV 
 
specific staining in red. 
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Figure 6. Maximum clade credibility tree constructed from ORF1b amino acid sequences   of 
 
the representatives of the subfamily Torovirinae. The phylogenetic tree was constructed using 
 
Bayesian MCMC method with LG+G+I model of substitution. Posterior probabilities are 
 
shown in each node. 
 
Figure  7.  Changes  in  the  lung  epithelium  in  Morelia  viridis  with    nidovirus-associated 
 
proliferative  pneumonia.  Representative  photomicrographs  (A,  C,  E,  animal  B4)        and 
 
ultramicrographs (B, D, F, animal A1) of diseased lungs (cross sections). A, B. Region 1.    A. 
 
The PAS/Alcian Blue stain highlights positive (arrowheads) secretory epithelial cells in all 
 
cell layers of the hyperplastic multilayered trabecular epithelium. Abundant mucus fills the 
 
lumen. B. The ultrastructural features of most cells (cytoplasmic mucous granules and short 
 
microvilli) show that they are secretory cells (50). Only a few ciliated cells are    seen (arrow). 
 
C-F. In regions 2 (C, D) and 3 (E, F), the faveolae are diffusely lined by cuboidal cells 
 
containing serous/mucous granules (C, E, arrowheads), consistent with type II   pneumocytes. 
 
Ultrastructurally, these cells resemble so-called “transformed” type II pneumocytes, as they 
 
contain  serous/mucous  granules  (arrows)  and  lack  the  lamellar  bodies  characteristic   for 
 
normal type II pneumocytes (51). 
 
Figure 8. Viral target cells in lungs and airways of Morelia viridis with   nidovirus-associated 
 
proliferative pneumonia. A-D. Animals A1 (A) and A2 (B-D), lung. The pseudostratified 
 
trabelular epithelium (region 1) exhibits abundant viral RNA mainly in superficial epithelial 
 
cell layers (A). B. Viral antigen expression is seen in all cell layers. In basal and mid layers, it 
 
is represented by a focal cytoplasmic reaction (arrowhead). The fully differentiated superficial 
 
epithelial cells exhibit abundant viral antigen (arrow) and loss of cilia. Infected cells are   also 
 
found shed into the lumen. C. Region 2. In areas with intact faveolar epithelium, both type I 
 
(arrowhead)  and  differentiated  type  II  pneumocytes  (arrows)  exhibit  strong  viral antigen 
 
expression. The new, hyperplastic type II pneumocytes in other areas display a weaker focal 
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cytoplasmic reaction (arrows). At the base of the faveolae (D), type I (arrowheads) and type II 
 
(arrows)  pneumocytes  are  also  found to  be infected.  They are also shed  into the   faveolar 
 
lumen.  E.  Animal  A1,  nasal  cavity.  The  epithelium  is  thickened  due  to  hyperplasia and 
 
exhibits  nidovirus  infection  mainly  of  the  fully  differentiated  superficial  epithelial   cells 
 
(arrow). C - cartilage. F. Animal A1, trachea. Bottom: The ciliated epithelium is largely intact 
 
(arrow),  but  there  are  scattered  individual  or  small  groups  of  infected  cells.   Sloughed, 
 
degenerate epithelial cells are also found to carry viral RNA (arrowhead). Top: Infected   cells 
 
are intact (arrowhead) or degenerate, shedding virus (arrow). C – tracheal ring cartilage. 
 
RNA-ISH  (RNAscope  technology;  A,  E,  F)  and  IH  (HRP  method;  B-D)  for  MVNV N 
 
protein, haematoxylin counterstain. Bars = 20 µm (A, E, F bottom) and 10 µm (B-D, F top). 
 
G. Ultramicrograph of a type II pneumocyte with staples of tubular structures of 100 – 150 
 
nm length (arrows). Bar = 1 µm. 
 
Figure 9. Illustration of the morphometric approach taken to measure the epithelial height and 
 
number of epithelial cell nuclei in cytokeratin-stained cross sections of the lungs. A. Three 
 
regions were defined in the proximal, bronchiolar lung: 1) The luminal part of the primary 
 
trabeculae, covered by a multilayered pseudostratified ciliated epithelium (1). 2) The faveolae 
 
at mid level (2) and at the base (3), covered by a single layered epithelium. B. Region 1, 
 
measurement of epithelial height. The blue lines represent 10 measurements taken over a  300 
 
µm wide epithelial segment, determining the distance between the apical epithelial cell border 
 
and the basal membrane. 200-fold magnification. C. Region 1, determination of cell   number. 
 
The total amount of epithelial nuclei (x) counted in a 200 µm wide epithelial segment. 400- 
 
fold magnification. D, E. Region 2 (D) and 3 (E), measurement of epithelial height. The   blue 
 
lines represent 10 measurements taken over a 300 µm wide epithelial segment, determining 
 
the  distance  between  the  apical  epithelial  cell  border  and  the  basal  membrane. 200-fold 
 
magnification. 
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Figure 10.The average epithelial height measured in three lung regions and the trachea of 
 
infected  animals  (white)  was  significantly  higher  than  in  non-infected  (control)  animals 
 
(gray).        Box plots illustrate the third quartile (Q3) and first quartile (Q1) range of the data, 
 
filled circles represent data outliers (>1.5x interquartile range). Boxplots were created by 
 
the SPSS Statistics software. A Mann-Whitney U test for independent samples (t-test) was 
 
used for statistical analysis, and a p-value of less than 0.05 was considered significant 
 
Figure  11.  Increased  epithelial  turnover  in  the  lungs  of  Morelia  viridis  with  nidovirus- 
 
associated proliferative pneumonia. Trabeculae (region 1). A, C. Diseased animal (C1). The 
 
hyperplastic   pseudostratified   epithelium   is   proliferating,   as   confirmed   by   the PCNA 
 
expression in almost all epithelial cells. Infiltrating lymphocytes (arrow; A) are also   positive. 
 
There  are  also  abundant,  cleaved  caspase  3-positive  apoptotic  epithelial  cells  (C).       A 
 
proportion of infiltrating leukocytes is also found to undergo apoptosis (arrow; C). B, D. 
 
Control animal (G3). In the control animal, only scattered individual basal epithelial cells  are 
 
found to express PCNA (arrowhead; B). Similarly, only rare epithelial cells are found to 
 
undergo apoptosis (arrowhead; D). Apoptosis (i.e. cleaved caspase-3 expression) is also   seen 
 
in occasional lymphocytes (arrow) of the lymphoid aggregates. IH for PCNA (A, B) and 
 
cleaved caspase-3 (C, D), HRP method, haematoxylin counterstain. Bars = 20 µm. 
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Table 1. Animals 
Animals tested positive for MVNV by RT-PCR, RNA-ISH and IH 
 
A
n
i
m
a
l 
A
g
e 
(
y
) 
S
e
x 
Clinical signs Diagnostic 
tests* A
1 
1 M No history Bacteriology 
A
2 
5 F Sudden death NGS 
A
3 
8 M Sudden death, mucus in oral cavity Bacteriology 
A
4 
n
p 
F Acute respiratory distress (1 day)  
B
1 
6 M 
Respiratory distress (3-4 days), 
expulsion of mucus 
Virology, 
virus 
isolation, 
NGS 
B
2 
7 F 
Respiratory distress (3-4 days), 
expulsion of mucus 
Virology 
C
1 
2
.
5 
M Chronic anorexia, acute respiratory 
distress 
Virology 
C
2 
8 M Respiratory  distress Virus 
isolation D
1 
6 F Respiratory distress (≥ 1 week) NGS 
E
1 
n
p 
F Respiratory distress (≥ 1 week)  
F
1 
2 F Sudden death  
G
1 
6 F Sudden death  
A - G: Breeding collections; Bacteriology – routine bacteriological examination performed on 
lungs; Virology – lung tissue screened for viruses (reovirus, paramyxovirus, Sunshine virus, 
nidovirus) in a commercial laboratory; NGS – Next generation sequencing on lung 
homogenates; y – years; np – not provided (adult); M – male, F – female; *Tests performed 
prior to or alongside MVNV RT-PCR, IHC and RNA-ISH 
 
 
Uninfected control animals (negative for MVNV by RT-PCR) 
 
A
n
i
m
a
l 
A
g
e 
(
y
) 
S
e
x 
Clinical signs Diagnosis 
G
2 
9 M Sudden death Mild colitis 
G
3 
6 F Emaciation, death Mild enteritis and 
nephritis G
4 
2 F Sudden death BIBD, severe purulent 
vasculitis around 
oesophagus and trachea G
5 
1 M Sudden death Focal suppur tive 
pneumonia in one lobe 
G: Breeding collection; y – years; M – male, F – female; 
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Table 2. HMMER3 analysis of functional domains in the ORFs detected in MVNV genome. 
   Alignment  E-value  
 Family id Accession Start End Bit Score Independent Conditional Description 
ORF1a Methyltransf_25 PF13649.5 3075 3150 15.08 0.027 4.80E-06 Methyltransferase domain 
 zf-CCCH PF00642.23 1052 1072 12.09 0.13 2.40E-05 Zinc finger C-x8-C-x5-C-x3-H type  
  PF00642.23 1098 1117 9.91 0.64 0.00011 Zinc finger C-x8-C-x5-C-x3-H type  
ORF1b NSP13 PF06460.11 2077 2239 50.2 1.80E-13 1.20E-16 Coronavirus NSP13 
 Viral_helicase1 PF01443.17 1144 1380 45.91 5.20E-12 3.40E-15 Viral (Superfamily 1) RNA helicase 
 AAA_30 PF13604.5 1101 1231 42.93 3.90E-11 2.60E-14 AAA domain 
 RdRP_1 PF00680.19 479 651 40.69 1.00E-10 6.60E-14 RNA dependent RNA polymerase 
 AAA_19 PF13245.5 1100 1229 33.98 3.10E-08 2.00E-11 AAA domain 
ORF5 Arteri_nucleo PF01481.15 32 132 23.35 5.50E-05 9.90E-09 Arterivirus nucleocapsid protein 
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Table 3. Nucleotide and amino acid identities comparing MVNV and the nidoviruses 
identified in 
Python molurus (Indian python) and Python regius (ball python). 
 
Nucleotide Amino acid 
 Python 
nidovirus 
S1536/13 
(KJ935003) 
Ball 
python 
nidovirus 
07-53 
(KJ54175
9) 
Python 
nidovirus 
S1536/13 
(KJ935003) 
Ball 
python 
nidovirus 
07-53 
(KJ54175
9) 
5´ 
UTR 
85.1 87.0   
ORF
1a 
72.8 72.8 69.5 69.6 
ORF
1b 
86.5 86.3 91.0 90.5 
ORF
2 
80.9 80.0 85.0 84.8 
ORF
3 
69.5 67.0 64.7 65.4 
ORF
4 
76.5 79.2 83.3 82.9 
ORF
5 
75.1 74.0 74.2 74.8 
ORF
6 
65.6 66.9 59.7 59.2 
ORF
7 
77.1 78.6 68.8 71.9 
3´ 
UTR 
95.2 93.9   
Com
plete 
77.3 77.3 77.2 77.1 
  genome/CDS  
In brackets: Genebank accession numbers. 
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Table 4. Results of the quantitative assessment of epithelial height and cellularity in lung and 
trachea of MVNV-positive animals (tested positive by RT-PCR, RNA-ISH and IH; n=12) in 
comparison to uninfected control animals (negative for MVNV by RT-PCR and IH; n=4). 
Lungs 
 
For all regions, the values are significantly different between infected and control animals 
(P<0.05). 1 Mean ± standard deviation 
 
Trachea 
 
Values are significantly different between infected and control animals 
(P<0.05). 1 Mean ± standard deviation 
 
Lung regions 1-3: 1) Multilayered pseudostratified epithelium covering the luminal part of 
the primary trabeculae; 2) Single layered epithelium at mid level of the faveolae; and 3) Single 
layered epithelium at the base of the faveolae. 
 
MVNV-positive animals1  Uninfected control animals2  
 
Epithelial height (µm)1 Number of nuclei1  Epithelial height (µm) 1 Number of nuclei1  
Region 1 62.97±25.39 62.97±25.39 24.96±26.13 6.54±0.81 
Region 2 24.4±14.16 14.97±3.57 6.61±14.59 8.83±0.76 
Region 3 17.43±8.1 15.22±2.66 6.46±8.41 10.33±0.85 
MVNV-positive animals1  Uninfected control animals2  
Epithelial height (µm) 1 Number of nuclei1  Epithelial height (µm) 1 Number of nuclei1  
61.5±14.06 82.33±39.15 28.21±5.74 44.25±12.09 
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